SITC Announces 2022 Class of Fellows to the Academy of Immuno-Oncology
Milwaukee, WI (PRWEB) July 14, 2022 -- The Society for Immunotherapy of Cancer (SITC) announces the 2022 class of Fellows of the Academy of Immuno-Oncology
Stay updated with breaking news from Lloydj Old. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Milwaukee, WI (PRWEB) July 14, 2022 -- The Society for Immunotherapy of Cancer (SITC) announces the 2022 class of Fellows of the Academy of Immuno-Oncology
Follicular lymphoma, a cancer of the white blood cells, is usually incurable. Patients cycle through periods of therapy that partially shrink their cancers, before the disease progresses again. That’s what appeared to be happening with a 61-year-old man in Italy: Diagnosed with cancer in August of 2019, he promptly began a course of chemotherapy, completing it in February 2020. All that was left to do was monitor the tumor’s growth. So when a June scan revealed that the patient’s tumor appeared to be growing, Martina Sollini, a professor of nuclear medicine at Humanitas University in It...
The Beginnings From ancient Egypt, some 3,000 years ago, to the early nineteenth century there have been multiple anecdotal reports of tumors disappearing spontaneously or after an infection with concomitant high fever (3, 4). The similarity between cancer and inflammation was described for the first time by the Greek physician, Galen, who noted that cancer might evolve from inflammatory lesions (5). The first scientific attempts to modulate patients' immune systems to cure cancer can be attributed to two German physicians, Fehleisen and Busch, who independently noticed significant tumor regr...